# SpO2/FiO2 ratio as a better metric for assessment of RBC transfusion effectiveness in non-traumatic critically ill patients with physiologic derangements

## TL;DR

This study suggests that the SpO2/FiO2 ratio is a better indicator than hemoglobin alone for assessing how well RBC transfusions work in critically ill non-trauma patients.

## Contribution

The study introduces the SpO2/FiO2 ratio as a novel and more effective biomarker for evaluating RBC transfusion efficacy.

## Key findings

- The SpO2/FiO2 ratio was found to be a more effective biomarker than hemoglobin alone for assessing RBC transfusion efficacy.
- A random forest-based regression model using SF data significantly evaluated transfusion effectiveness (p < 0.001).
- The inverse correlation between pre-transfusion SF ratio and transfusion efficacy was consistent across two centers.

## Abstract

Identifying critically ill patients who are likely to improve their respiratory physiology following RBC transfusion is dynamic and difficult. Current decision tools are over-reliant on hemoglobin transfusion thresholds, without considering respiratory measures that may reflect physiologic effects of anemia and functional responses to RBC transfusion. Further, routine clinical measures to determine transfusion efficacy beyond hemoglobin increment are lacking to identify patients as responders or non-responders. We present a two-center retrospective cohort study aiming to determine a potential biomarker to assess the physiologic response of RBC transfusion for non-traumatic ICU patients. The study was performed with 13,274 eligible patients at the first center. Another 3,757 from the second center were used as a validation population. We introduced a comparative analysis of two respiratory measures, SpO2 and SpO2/FiO2 (SF) ratio, in addition to hemoglobin, to assess individual patient responses to RBC transfusion. A statistical study was performed to compare these markers before and after the transfusion interval. Based on quantitative statistical analyses, we found SF ratio to be a more effective biomarker than hemoglobin alone for revealing RBC transfusion efficacy. There existed an inverse correlation between pre-transfusion SF and transfusion efficacy. The results were consistent across both centers, revealing generalizability. With the SF data from both the centers, we also developed a random forest-based regression model that significantly evaluated the level of transfusion effectiveness (p < 0.001).